# Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease

> **NCT02906488** · — · COMPLETED · sponsor: **AbbVie** · enrollment: 839 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02906488
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-12
- **Primary completion:** 2025-07-24
- **Final completion:** 2025-07-24
- **Target enrollment:** 839 (ACTUAL)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02906488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02906488, "Special Drug Use-results Survey of Duodopa Enteral Solution in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02906488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*